Literature DB >> 32629000

circPAN3 exerts a profibrotic role via sponging miR-221 through FoxO3/ATG7-activated autophagy in a rat model of myocardial infarction.

Fei Li1, Tian-Yi Long1, Si-Si Bi1, Sayed Ali Sheikh2, Cheng-Long Zhang3.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Cardiac fibrosis is the scarring process occurs commonly with CVDs impairing the function and structure of heart. Herein, we investigated the role of circPAN3 in the pathogenesis of cardiac fibrosis.
METHODS: A rat myocardial infarction (MI) model was constructed to evaluate the role of circPAN3. Expression of circPAN3 in MI was determined, and si-circPAN3 was applied to verify its profibrotic effects. With an in vitro model, cardiac fibroblasts were stimulated by transforming growth factor beta 1 (TGFβ1). Immunofluorescent staining was employed to assess the fibrosis-related markers, as well as autophagy activity. CCK-8 and transwell assays were performed to determine cell proliferation and migration. Luciferase reporter assay and RNA pull-down were subjected to verify the interaction of circPAN3/miR-221. The enrichment of FoxO3 on the promoter region of ATG7 was detected using CHIP assay.
RESULTS: Elevated circPAN3 was found in rat MI heart tissue, of which knockdown attenuated cardiac fibrosis after MI. In an in vitro model exposing with TGFβ1, increasing cell proliferation and migration were observed, whereas these effects were abolished by circPAN3 knockdown, as well as autophagy activity. miR-221 was identified as a target to be involved in circPAN3-mediated cardiac fibrosis after MI. miR-221 negatively regulated FoxO3, thus causing the inhibition of ATG7 transcription. The regulatory network of circPAN3/miR-221/FoxO3/ATG7 in cardiac fibrosis was further determined in vivo.
CONCLUSION: circPAN3 exhibited profibrotic effects during autophagy-mediated cardiac fibrosis via miR-221/FoxO3/ATG7 axis, which may serve as potential biomarkers for cardiac fibrosis therapeutics.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Autophagy; Cardiac fibrosis; circPAN3; miR-221

Year:  2020        PMID: 32629000     DOI: 10.1016/j.lfs.2020.118015

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  The Networks of Noncoding RNAs and Their Direct Molecular Targets in Myocardial Infarction.

Authors:  Shiqi Wang; Yang Wang; Hongxin Cheng; Qing Zhang; Chenying Fu; Chengqi He; Quan Wei
Journal:  Int J Biol Sci       Date:  2022-05-01       Impact factor: 10.750

Review 2.  The influence of circular RNAs on autophagy and disease progression.

Authors:  Yian Wang; Yongzhen Mo; Miao Peng; Shanshan Zhang; Zhaojian Gong; Qijia Yan; Yanyan Tang; Yi He; Qianjin Liao; Xiayu Li; Xu Wu; Bo Xiang; Ming Zhou; Yong Li; Guiyuan Li; Xiaoling Li; Zhaoyang Zeng; Can Guo; Wei Xiong
Journal:  Autophagy       Date:  2021-04-27       Impact factor: 16.016

Review 3.  Circular RNAs and Cardiovascular Regeneration.

Authors:  Ling Tang; Pengsheng Li; Michelle Jang; Wuqiang Zhu
Journal:  Front Cardiovasc Med       Date:  2021-04-13

Review 4.  Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics.

Authors:  Jinhong Chen; Zhichao Liu; Li Ma; Shengwei Gao; Huanjie Fu; Can Wang; Anmin Lu; Baohe Wang; Xufang Gu
Journal:  Front Genet       Date:  2021-12-20       Impact factor: 4.599

5.  miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2.

Authors:  Ran Cheng; Hao Xu; Yang Hong
Journal:  Mol Med Rep       Date:  2021-09-09       Impact factor: 2.952

Review 6.  The circRNA-miRNA/RBP regulatory network in myocardial infarction.

Authors:  Lei Zhang; Yuan Zhang; Fei Yu; Xin Li; Huijuan Gao; Peifeng Li
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

Review 7.  Circle the Cardiac Remodeling With circRNAs.

Authors:  Tiqun Yang; Tianxin Long; Tailai Du; Yili Chen; Yugang Dong; Zhan-Peng Huang
Journal:  Front Cardiovasc Med       Date:  2021-06-25

Review 8.  Circular RNAs as Competing Endogenous RNAs in Cardiovascular and Cerebrovascular Diseases: Molecular Mechanisms and Clinical Implications.

Authors:  Xue Min; Dong-Liang Liu; Xing-Dong Xiong
Journal:  Front Cardiovasc Med       Date:  2021-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.